Journal of Clinical Oncology
ASCO issues recommendations to improve cancer survivor care
(HealthDay)—The American Society of Clinical Oncology (ASCO) has presented recommendations for promoting high-quality cancer survivorship care in a report published online Jan. 7 in the Journal of Clinical On ...
Cancer
Jan 10, 2013 |
not rated yet |
0
Ovarian cancer rates declining in breast cancer survivors
(HealthDay)—Primary ovarian cancer incidence is declining in the United States, both among the general population and among breast cancer survivors, according to research published online Jan. 2 in the ...
Cancer
Jan 08, 2013 |
not rated yet |
0
Centralization to fewer surgeons results in better survival after esophageal cancer surgery
Patients who undergo surgery for oesophageal cancer have a much greater chance of long term survival if the operation is carried out by a surgeon who has performed this particular operation many times before. This according ...
Cancer
Jan 07, 2013 |
not rated yet |
0
E-mail prompts improve code status documentation
(HealthDay)—For patients with advanced lung cancer, prompting oncologists via e-mail successfully improved both the rate and timing of outpatient code status documentation in patients' electronic health ...
Cancer
Jan 05, 2013 |
not rated yet |
0
Nurse-led monitoring improves cancer-related fatigue
(HealthDay)—For patients with advanced cancer, nurse-led monitoring and optimized treatment of physical symptoms significantly improves cancer-related fatigue, according to research published online Jan. ...
Cancer
Jan 04, 2013 |
not rated yet |
0
Administering chemo ups income for non-salaried oncologists
(HealthDay)—Non-salaried oncologists report the potential for increased salaries with the administration of chemotherapy or growth factors for lung or colorectal cancer patients, according to a study published ...
Cancer
Jan 02, 2013 |
not rated yet |
0
Longitudinal algorithm may detect ovarian cancer earlier
(HealthDay)—Compared with a single-threshold (ST) rule, a parametric empirical Bayes (PEB) longitudinal screening algorithm can identify ovarian cancer earlier and at a lower concentration of CA125, according ...
Cancer
Dec 21, 2012 |
not rated yet |
0
No training means spiritual care lacking in advanced cancer
(HealthDay)—Although oncology nurses and physicians feel that spiritual care (SC) is an important, appropriate, and beneficial component of end-of-life (EOL) care for patients with advanced cancer, it is ...
Cancer
Dec 21, 2012 |
not rated yet |
0
Polygenic risk score helpful for women with familial breast CA
(HealthDay)—For women affected by familial breast cancer, a polygenic risk score based on 22 genomic variants can identify women at high-risk of breast cancer, according to a study published in the Dec. ...
Cancer
Dec 18, 2012 |
not rated yet |
0
PR+ cells add prognostic value in luminal A breast cancer
(HealthDay)—Semiquantitative immunohistochemical expression of progesterone receptor-positive tumor cells improves prediction of survival within luminal A breast cancers, according to a study published ...
Cancer
Dec 17, 2012 |
not rated yet |
0
Despite cART, anal cancer risk still high for HIV-infected
(HealthDay)—For HIV-infected patients, despite combined antiretroviral treatment (cART), the risk of anal cancer is still much higher than in the general population, according to a study published in the ...
HIV & AIDS
Dec 13, 2012 |
not rated yet |
0
40 percent of cancer patients receive opioids at end of life
(HealthDay)—For patients with one of five common cancers, 43.6 percent receive at least one prescription of opioids in the last three months of life, according to a study published in the Dec. 10 issue ...
Medications
Dec 13, 2012 |
not rated yet |
0
Older and younger chronic leukemia patients may need different therapy
Doctors should use different therapies when treating older and younger patients with chronic lymphocytic leukemia, according to a new study led by researchers at the Ohio State University Comprehensive Cancer Center – Arthur ...
Cancer
Dec 12, 2012 |
not rated yet |
0
|
Bevacizumab doesn't prolong survival in stage II-III colon CA
(HealthDay)—For patients with stage 2 to 3 colon cancer, the addition of bevacizumab to modified fluorouracil, leucovorin, and oxaliplatin (FOLFOX6) does not prolong disease-free or overall survival, according ...
Cancer
Dec 12, 2012 |
not rated yet |
0
Inherited gene fault influences breast cancer survival
Researchers have shown that an inherited gene fault influences the chances of some women surviving breast cancer. It also increases the risk of women developing a second breast cancer. The research is publishe ...
Cancer
Dec 11, 2012 |
not rated yet |
0
